Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature - PubMed (original) (raw)
. 2006 Jul-Sep;72(1-2):54-61.
doi: 10.1016/j.mvr.2006.03.004. Epub 2006 May 19.
Affiliations
- PMID: 16713605
- DOI: 10.1016/j.mvr.2006.03.004
Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature
Gopalakrishnapillai Anilkumar et al. Microvasc Res. 2006 Jul-Sep.
Abstract
Prostate-specific membrane antigen (PSMA) is a transmembrane protein with a highly restricted profile of expression. Expression is primarily limited to secretory cells of the prostatic epithelium, with elevated levels observed in prostate cancer. As an integral membrane protein correlated with prostate cancer, PSMA offers a potentially valuable target for immunotherapy. PSMA is also detected in the neovasculature of a variety of solid tumors but not in the endothelial cells of preexisting blood vessels. Although the significance of PSMA expression in these cells remains elusive, this pattern of expression implies that PSMA may perform a functional role in angiogenesis and may offer a therapeutic target for the treatment of a broad spectrum of solid tumors. In this study, we have expressed PSMA in human microvascular endothelial cells and demonstrate that PSMA binds to caveolin-1 and undergoes internalization via a caveolae-dependent mechanism. The association between PSMA and caveolae in endothelial cells may provide important insight into PSMA function and ways to best exploit this protein for therapeutic benefit.
Similar articles
- Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
Haffner MC, Kronberger IE, Ross JS, Sheehan CE, Zitt M, Mühlmann G, Ofner D, Zelger B, Ensinger C, Yang XJ, Geley S, Margreiter R, Bander NH. Haffner MC, et al. Hum Pathol. 2009 Dec;40(12):1754-61. doi: 10.1016/j.humpath.2009.06.003. Epub 2009 Aug 27. Hum Pathol. 2009. PMID: 19716160 - Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB. Chang SS, et al. Cancer Res. 1999 Jul 1;59(13):3192-8. Cancer Res. 1999. PMID: 10397265 - Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
Baccala A, Sercia L, Li J, Heston W, Zhou M. Baccala A, et al. Urology. 2007 Aug;70(2):385-90. doi: 10.1016/j.urology.2007.03.025. Urology. 2007. PMID: 17826525 - PSMA expression on neovasculature of solid tumors.
Van de Wiele C, Sathekge M, de Spiegeleer B, De Jonghe PJ, Debruyne PR, Borms M, Beels L, Maes A. Van de Wiele C, et al. Histol Histopathol. 2020 Sep;35(9):919-927. doi: 10.14670/HH-18-215. Epub 2020 Apr 13. Histol Histopathol. 2020. PMID: 32282924 Review. - Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
Ghosh A, Heston WD. Ghosh A, et al. J Cell Biochem. 2004 Feb 15;91(3):528-39. doi: 10.1002/jcb.10661. J Cell Biochem. 2004. PMID: 14755683 Review.
Cited by
- Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer.
Bakht MK, Beltran H. Bakht MK, et al. Nat Rev Urol. 2025 Jan;22(1):26-45. doi: 10.1038/s41585-024-00900-z. Epub 2024 Jul 8. Nat Rev Urol. 2025. PMID: 38977769 Review. - The "Ins and Outs" of Prostate Specific Membrane Antigen (PSMA) as Specific Target in Prostate Cancer Therapy.
Eltit F, Robinson N, Yu PLI, Pandey M, Lozada J, Guo Y, Sharma M, Ozturan D, Ganier L, Belanger E, Lack NA, Perrin DM, Cox ME, Goldenberg SL. Eltit F, et al. Adv Exp Med Biol. 2023;1408:291-308. doi: 10.1007/978-3-031-26163-3_16. Adv Exp Med Biol. 2023. PMID: 37093434 - Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer.
Murelli RP, Zhang AX, Michel J, Jorgensen WL, Spiegel DA. Murelli RP, et al. J Am Chem Soc. 2009 Dec 2;131(47):17090-2. doi: 10.1021/ja906844e. J Am Chem Soc. 2009. PMID: 19888723 Free PMC article. - More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.
Hyväkkä A, Virtanen V, Kemppainen J, Grönroos TJ, Minn H, Sundvall M. Hyväkkä A, et al. Cancers (Basel). 2021 May 7;13(9):2244. doi: 10.3390/cancers13092244. Cancers (Basel). 2021. PMID: 34067046 Free PMC article. Review. - Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors.
Pereira PMR, Mandleywala K, Ragupathi A, Lewis JS. Pereira PMR, et al. Clin Cancer Res. 2020 Dec 1;26(23):6215-6229. doi: 10.1158/1078-0432.CCR-20-1960. Epub 2020 Sep 30. Clin Cancer Res. 2020. PMID: 32998959 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous